Loading company…
RubrYc Therapeutics develops molecular therapeutic antibodies using its machine learning and computational biology platform.
Founded in 2017 and based in San Carlos, California, US, RubrYc Therapeutics, Inc. is a biotechnology company that develops molecular therapeutic antibodies using its proprietary machine learning and computational biology technologies. The company is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in